Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7E3C

SARS-CoV-2 spike in complex with the Ab1 neutralizing antibody (focused refinement on Fab-RBD)

7E3C の概要
エントリーDOI10.2210/pdb7e3c/pdb
EMDBエントリー30979
分子名称Spike protein S1, Light chain of Ab1, Heavy chain of Ab1, ... (4 entities in total)
機能のキーワードspike, sars-cov-2, antibody, viral protein, viral protein-immune system complex, viral protein/immune system
由来する生物種Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
詳細
タンパク質・核酸の鎖数3
化学式量合計94122.40
構造登録者
Liu, C. (登録日: 2021-02-08, 公開日: 2021-09-01, 最終更新日: 2024-10-30)
主引用文献Nie, J.,Xie, J.,Liu, S.,Wu, J.,Liu, C.,Li, J.,Liu, Y.,Wang, M.,Zhao, H.,Zhang, Y.,Yao, J.,Chen, L.,Shen, Y.,Yang, Y.,Wang, H.W.,Wang, Y.,Huang, W.
Three epitope-distinct human antibodies from RenMab mice neutralize SARS-CoV-2 and cooperatively minimize the escape of mutants.
Cell Discov, 7:53-53, 2021
Cited by
PubMed Abstract: Coronavirus disease 2019 (COVID-19), a pandemic disease caused by the newly emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused more than 3.8 million deaths to date. Neutralizing antibodies are effective therapeutic measures. However, many naturally occurring mutations at the receptor-binding domain (RBD) have emerged, and some of them can evade existing neutralizing antibodies. Here, we utilized RenMab, a novel mouse carrying the entire human antibody variable region, for neutralizing antibody discovery. We obtained several potent RBD-blocking antibodies and categorized them into four distinct groups by epitope mapping. We determined the involved residues of the epitope of three representative antibodies by cryo-electron microscopy (Cryo-EM) studies. Moreover, we performed neutralizing experiments with 50 variant strains with single or combined mutations and found that the mixing of three epitope-distinct antibodies almost eliminated the mutant escape. Our study provides a sound basis for the rational design of fully human antibody cocktails against SARS-CoV-2 and pre-emergent coronaviral threats.
PubMed: 34285195
DOI: 10.1038/s41421-021-00292-z
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (4.2 Å)
構造検証レポート
Validation report summary of 7e3c
検証レポート(詳細版)ダウンロードをダウンロード

237423

件を2025-06-11に公開中

PDB statisticsPDBj update infoContact PDBjnumon